Pharming Group N.V.
Joenja
APDS
Resolved
103days ago
Phase 2 readout · Mar 26, 2026
What's at stake
Phase 2 trial results for Joenja in APDS are due Mar 26, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“the CHMP adopted a positive opinion recommending marketing authorization for Joenja® (leniolisb) in adult and pediatric patients aged 12 years and older.”